[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2005084648A8 - Compositions pharmaceutiques comprenant du candesartan cilexetil - Google Patents

Compositions pharmaceutiques comprenant du candesartan cilexetil

Info

Publication number
WO2005084648A8
WO2005084648A8 PCT/IB2005/000494 IB2005000494W WO2005084648A8 WO 2005084648 A8 WO2005084648 A8 WO 2005084648A8 IB 2005000494 W IB2005000494 W IB 2005000494W WO 2005084648 A8 WO2005084648 A8 WO 2005084648A8
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical compositions
candesartan cilexetil
cilexetil
candesartan
processes
Prior art date
Application number
PCT/IB2005/000494
Other languages
English (en)
Other versions
WO2005084648A1 (fr
Inventor
Romi Barat Singh
Girish Karanth
Vishnubhotla Naga Prasad
Original Assignee
Ranbaxy Lab Ltd
Romi Barat Singh
Girish Karanth
Vishnubhotla Naga Prasad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd, Romi Barat Singh, Girish Karanth, Vishnubhotla Naga Prasad filed Critical Ranbaxy Lab Ltd
Publication of WO2005084648A1 publication Critical patent/WO2005084648A1/fr
Publication of WO2005084648A8 publication Critical patent/WO2005084648A8/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne des compositions pharmaceutiques orales stables comprenant du candésartan cilexetil et un polymère soluble dans l'eau, ainsi que des procédés de préparation desdites compositions.
PCT/IB2005/000494 2004-02-27 2005-02-25 Compositions pharmaceutiques comprenant du candesartan cilexetil WO2005084648A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN308DE2004 2004-02-27
IN308/DEL/2004 2004-02-27

Publications (2)

Publication Number Publication Date
WO2005084648A1 WO2005084648A1 (fr) 2005-09-15
WO2005084648A8 true WO2005084648A8 (fr) 2005-12-15

Family

ID=34917508

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/000494 WO2005084648A1 (fr) 2004-02-27 2005-02-25 Compositions pharmaceutiques comprenant du candesartan cilexetil

Country Status (1)

Country Link
WO (1) WO2005084648A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI494134B (zh) * 2006-06-20 2015-08-01 Siegfried Generics Int Ag 含有坎地沙坦酯的組成物、錠劑和顆粒及該錠劑的製造方法
WO2008045006A1 (fr) * 2006-10-11 2008-04-17 Fako Ilaclari A. S. Formulations de candésartan
WO2008068727A2 (fr) * 2006-12-06 2008-06-12 Ranbaxy Laboratories Limited Composition pharmaceutique comprenant du candésartan cilexétil
EP1952806A1 (fr) 2007-02-01 2008-08-06 Helm AG Procédé de préparation des produits d'absorption de candesartan
PL384680A1 (pl) * 2007-03-28 2008-09-29 Zak & Lstrok Ady Farmaceutyczn Kompozycja farmaceutyczna zawierająca kandesartan cyleksetylu oraz sposób jej wytwarzania
WO2009013237A2 (fr) * 2007-07-20 2009-01-29 Krka, D.D. Novo Mesto Composition pharmaceutique solide stable comprenant du candesartan ou ses formes pharmaceutiquement acceptables
EP2050440A1 (fr) * 2007-10-18 2009-04-22 Krka Composition pharmaceutique solide stable comprenant du candesartan ou ses formes pharmaceutiquement acceptables
DE102007052070A1 (de) 2007-10-30 2009-05-07 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Candesartancilexetil
SI2165702T1 (sl) 2008-09-17 2012-05-31 Helm Ag Stabilni in z lahkoto raztopljeni sestavki kandesartan cileksetila pripravljeni z vlažno granulacijo
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
ES2364011B1 (es) 2009-11-20 2013-01-24 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
CZ302789B6 (cs) * 2009-11-25 2011-11-09 Zentiva, K. S. Zpusob zvýšení rozpustnosti farmaceuticky aktivních látek a cílený (kontrolovaný) transport do streva
CA2872542A1 (fr) 2012-05-07 2013-11-14 Bayer Pharma Aktiengesellschaft Procede pour fabriquer une forme pharmaceutique comprenant de la nifedipine et du candesartan cilexetil
KR101710441B1 (ko) 2015-12-28 2017-02-28 신풍제약주식회사 안정성 및 용출성이 향상된 정제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU742506B2 (en) * 1997-10-17 2002-01-03 Eurogene Limited The use of inhibitors of the renin-angiotensin system
ES2347968T3 (es) * 1998-07-28 2010-11-26 Takeda Pharmaceutical Company Limited Preparacion solida que se disgrega rapidamente.
CA2420844A1 (fr) * 2000-08-30 2003-02-28 Sankyo Company, Limited Compositions medicinales utilisees dans la prevention ou le traitement de l'insuffisance cardiaque

Also Published As

Publication number Publication date
WO2005084648A1 (fr) 2005-09-15

Similar Documents

Publication Publication Date Title
WO2008006528A3 (fr) Nouvelles compositions pharmaceutiques comprenant du lévétiracétam
WO2007019439A3 (fr) Compositions de copolymere sequence et utilisations de ces dernieres
IL195488A (en) Compounds, pharmaceuticals containing them and their uses
IL180115A0 (en) A conjugate of a factor ix moiety and a polymer, compositions containing the same and methods for the preparation thereof
WO2006127941A3 (fr) Hydrochlorure de cinacalcet amorphe et sa preparation
IL181301A0 (en) Cyclopamine analogues, pharmaceutical compositions comprising them and uses thereof
IL181618A0 (en) Pharmaceutical solid-in-oil compositions for external administraton, methods for preparation and uses thereof
IL189439A0 (en) Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
IL177533A (en) Benzimidazole derivatives, their preparation and pharmaceutical compositions comprising them
IL229304A (en) Compounds 1 ', 3' - Imaging Converts - 4 - Phenyl - 3, 4, 5, 6 - Tetrahydro - 2h, 1'h, [1, 4 '] Bipyridinyl - 2' - lozenges, pharmaceutical preparations containing them and their use
WO2005084648A8 (fr) Compositions pharmaceutiques comprenant du candesartan cilexetil
PL1968990T3 (pl) Rozpuszczalny w wodzie związek benzoazepinowy i jego kompozycja farmaceutyczna
IL181022A0 (en) Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical compositions comprising the same
WO2005079751A3 (fr) Compositions pharmaceutiques orales de candesartan cilexetil
WO2007083190A3 (fr) Extrait d'helychrisum insoluble dans l'eau, et procédés d'élaboration et d'utilisation correspondants
WO2008073863A3 (fr) Préparation et utilité d'allylamines substituées
ME01453B (me) Čvrste farmaceutske kompozicije koje sadrže valsartan
WO2007125521A3 (fr) Formes polymorphiques de l'acide zolédronique et leurs procédés de synthèse
IL192824A (en) Peptide compounds, pharmaceuticals containing them and their use
ATE479427T1 (de) Pharmazeutische zusammensetzung mit candesartan- cilexetil
ZA200705131B (en) Solid pharmaceutical composition comprising valsartan
WO2008060546A3 (fr) Formulations orales
WO2007099555A3 (fr) Compositions pharmaceutiques contenant de l'irbésartan
WO2006056696A3 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
WO2006069159A3 (fr) Compositions pharmaceutiques comprenant des composes de benzimidazole amorphe

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 37/2005 UNDER (74) REPLACE "C/O DESHMUCK, JAY, R." BY "C/O DESHMUKH, JAY, R."

122 Ep: pct app. not ent. europ. phase